| 000 | 01510 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515032245.0 | ||
| 264 | 0 | _c20060728 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0038-4348 | ||
| 024 | 7 |
_a10.1097/01.smj.0000221637.90495.66 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDowney, Timothy W | |
| 245 | 0 | 0 |
_aAdherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting. _h[electronic resource] |
| 260 |
_bSouthern medical journal _cJun 2006 |
||
| 300 |
_a570-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlendronate _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aEtidronic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aManaged Care Programs |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 |
_aPatient Compliance _xstatistics & numerical data |
| 650 | 0 | 4 |
_aRaloxifene Hydrochloride _xadministration & dosage |
| 650 | 0 | 4 | _aRisedronic Acid |
| 700 | 1 | _aFoltz, Susan H | |
| 700 | 1 | _aBoccuzzi, Stephen J | |
| 700 | 1 | _aOmar, Mohamed A | |
| 700 | 1 | _aKahler, Kristijan H | |
| 773 | 0 |
_tSouthern medical journal _gvol. 99 _gno. 6 _gp. 570-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.smj.0000221637.90495.66 _zAvailable from publisher's website |
| 999 |
_c16393543 _d16393543 |
||